EUPRAXIA PHARMACEUTICALS INC. (EPRX)

Every figure this model derived for EPRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 80,563,482 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 85,098,550 AssetsCurrent 2025-12-31
current liabilities 5,628,005 LiabilitiesCurrent 2025-12-31
equity 82,041,436 StockholdersEquity 2025-12-31
interest expense 0 InterestExpense 2025-12-31
ocf -28,552,218 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 0 Revenues 2025-12-31
sbc 8,756,107 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up EPRX on one particular measure came for.

RatioValue
current ratio15.12
current ratio reported15.12
dilution pct17.77
roic-2054.39

What to be careful about

What this model itself distrusts about EPRX's figures. Written by the derivation as it ran, not added afterwards.